An experimental and algorithm-based study of the spectral features of breast cancer patients by a photodiagnosis approach

Photodiagnosis Photodyn Ther. 2020 Sep:31:101851. doi: 10.1016/j.pdpdt.2020.101851. Epub 2020 Jun 1.

Abstract

In the present study, the spectral diagnosis of blood plasma samples of breast cancer patients and an equal number of normal controls was investigated. A set of ratio parameters was acquired by employing SXS and FES. The samples were also analyzed statistically by employing Welch two-sample t-tests, and the effects of three ratio parameters, R1, R2, and R3, were also studied by plotting them against the subject numbers. A linear discriminant was also applied to verify the exact classification of normal control and breast cancer patients. It was observed that the levels of biofluorophores such as porphyrin, NADH, tryptophan and flavins were elevated 2- to 3-fold for breast cancer patients compared to normal controls, with an accuracy of approximately 100 %. We have also confirmed the validity of the obtained experimental results by using an advanced robust diagnostic algorithm. The experimental results of the current study may have a vital and substantial impact on the detection and screening protocols used for future breast cancer patients. The spectral analysis of body fluid could be of great value to add to and enhance the current procedures with an accuracy of approximately 100 % with limited number of samples. The results and objectives of this preliminary study were encouraging and useful for the discrimination of the features of breast cancer patients compared to those of normal controls.

Keywords: Biomarkers; Blood plasma; Breast cancer detection; Fluorescence spectra.

MeSH terms

  • Algorithms
  • Breast Neoplasms* / diagnosis
  • Humans
  • Photochemotherapy* / methods
  • Photosensitizing Agents
  • Porphyrins*

Substances

  • Photosensitizing Agents
  • Porphyrins